AEVI GENOMIC Cash Flow - Annual (NASDAQ:GNMX)

Add to My Stocks
$1.22 $0.04 (3.39%) GNMX stock closing price Jun 20, 2018 (Closing)

The AEVI GENOMIC cash flow statement helps investors understand how well the company is managing its cash flows. This report provides details about cash inflows and outflows due to the company's business and investment activities, and summarize cash outflows for a given quarter. For AEVI GENOMIC profits one has to check the income statement and for AEVI GENOMIC debt one has to check the balance sheet. AEVI GENOMIC had cash and cash equivalents of $39.83M at beginning of the year and $33.72M at year end for 2017. AEVI GENOMIC cash flow analysis tells whether or not the company has enough cash for its day to day activities, and for investing for future growth. AEVI GENOMIC saw a outflow of $- from investing activities for 2017.

View details of AEVI GENOMIC cash flows for latest & last 10 financial years
show more
Quarterly
Annual
View Previous Years
View Next Years
Fiscal year is Jan - Dec2017201620152014201320122011
Net Income Cash Flow
-34.71M-41.9M-37.99M-18.43M-17.12M-15.07M-8.09M
Depreciation Depletion Amortization Cash-Flow-------
Net Increase (Decrease) in Assets Liabilities-2.04M2.09M-0.1M----0.71M
Cash From (used in) Discontinued Operations-------
Other Adjustments Net3.4M6.78M13.5M5.54M3.64M5.47M-
Net Cash from (used by) Operating Activities
-33.24M-32.74M-24.34M-12.19M-12.73M-8.61M-8.01M
Increase (Decrease) in Prop Plant And Equipment--0.22M-0.18M-0.36M-0.18M-0.06M-0.28M
Acquisition Disposition of Subsidiaires-------
Increase (Decrease) in Investments-------
Other Cash Inflow (Outflow) from Investment Activities------0.01M-0.01M
Net Cash from (used by) Investment Activities
--0.22M-0.18M-0.36M-0.18M-0.06M-0.29M
Issuance (Purchase) of Equity Shares26.98M19.74M44.31M23.45M28.87M10.11M10.45M
Issuance (Repayment) of Debt Securities-------
Increase (Decrease) in Bank & Other Borrowings-------
Payment of Dividends & Other Cash Distributions-------
Other Cash from (used by) Financing Activities-------
Net Cash from (used by) Financing Activities
26.98M19.74M44.31M23.45M28.87M10.11M10.45M
Effect of Exchange Rate Changes on Cash-------
Net Change in Cash & Cash Equivalents
-6.1M-13.22M19.77M10.89M15.95M1.43M2.13M
Cash & Equivalents at Beginning of Year39.83M53.06M33.28M22.39M6.43M4.99M2.85M
Cash & Equivalents at Year End33.72M39.83M53.06M33.28M22.39M6.43M4.99M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

AEVI GENOMIC stock price history provides insight into historical stock price fluctuations, and AEVI GENOMIC stock comparison chart enables peer comparison. Some of the key terms used in the statement of cash flows are:

  • AEVI GENOMIC had a Net Change in Cash and Cash Equivalents of $-6.1M for the latest year 2017. If a firm is able to grow its cash, it is considered to be a positive signal and could lead to a jump in the AEVI GENOMIC stock price, albeit too much cash on hand can imply the company has no or limited avenues for growth in which to invest this cash.
  • Cash Flow from operating activities: This is the cash that the company receives from ongoing operations. AEVI GENOMIC lost $-33.24M cash from operations. It is important to check this to see where the company is getting its money from.
  • Growth companies, typically most tech companies; spend heavily on investing activities and this figure stood at $- for GNMX stock. Sometimes a company might have a negative overall cash flow which may not be really bad if it is due to investment expenses. Hence it is important to check the cash flow from investment activities.
  • Inflow of cash in the form of bank loans and shareholders equity, and outflow of cash because of dividend payments, share repurchase payments etc. come under financing activities. The cash generated from these activities was $26.98M for AEVI GENOMIC.

Key Financial Ratios For AEVI GENOMIC Cash Flow